The University of Queensland, The School of Medicine, Royal Brisbane and Women’s Hospital, QLD, 4029.
Australia
Director: Prof Jeffrey Lipman
Chair: Dr Jennifer Paratz
Research Manager: Dr Sia Athanasas
RESEARCH TOPICS
Burns and Trauma Management
The tyranny of distance, an evaluation of factors impacting on management of trauma patients
during transfer to major hospitals. Suitable for Masters or PhD
Exercise in patients with burns – psychological health and metabolism – are they interlinked?
Suitable for Honours, Masters or PhD
An expedited diagnosis of sepsis in burns. Suitable for Honours
Inhalation injury post burns – how does this affect right heart function? Suitable for Honours
Adrenergic blockade in burns – can this improve outcome? Suitable for Honours
Cardiovascular health in patients post burns. Suitable for Honours or Masters.
Contact:
Dr Jennifer Paratz
3636 1980
[email protected]
Burns and Trauma Therapy
Antibiotic levels in burn – determining optimisation of antibiotic therapy in burns using
microdialysis. Suitable for PhD
Wound surface in Operating Room temp and coagulation burn surgery – wound temp is cooler than
core temp and believed to impact on continual oozing of wound. Suitable for PhD
Pelvic packing – trauma, clinical descriptive study, pelvic fractures cause internal bleeding and so
determine if packing prevents deaths. Suitable for PhD
Finger escharotomy - does it add anything? Determine if this procedure improves circulation and
oxygen diffusion in burns patients. Suitable for Masters or PhD
Fluid resuscitation in burns –changes in paradigm due to our previous research ...patients with less
fluid resuscitation may be susceptible to renal dysfunction. Suitable for PhD
Prof Jeffrey Lipman +61 7 3636 8897 +61 7 3636 3542 [email protected]
Dr Jennifer Paratz +61 7 3636 1980 +61 7 3636 3542 [email protected]
Dr Sia Athanasas +61 7 3346 4932 +61 7 3365 5192 [email protected]
www2.som.uq.edu.au/som/Research/ResearchCentres/burnstraumacriticalcare
The University of Queensland, The School of Medicine, Royal Brisbane and Women’s Hospital, QLD, 4029.
Australia
Director: Prof Jeffrey Lipman
Chair: Dr Jennifer Paratz
Research Manager: Dr Sia Athanasas
Burn mortality – retrospective study, data already collected, paper needs to be written. Suitable for
Honours
Contact:
Assoc. Prof Michael Muller
3636 8314
[email protected]
Antibiotic Dosing and Pharmacokinetics in Critical Illness
Characterization of in vitro renal replacement therapy models to simulate antibiotic
pharmacokinetics in critically ill patients. Suitable for PhD
Antibiotic pharmacokinetics and dosing requirements for obese critically ill patients. Suitable for
PhD
Validation of dosing nomograms for optimising antibiotic prescription in critically ill patients
receiving renal replacement therapy. Suitable for PhD
Characterising the relationship between antibiotic exposure and bacterial clearance in critically ill
patients. Suitable for PhD
Antibiotic pharmacokinetics in the initial post injury phase in critically ill trauma patients. Suitable
for PhD
Contact:
Dr Jason Roberts
36364108
[email protected]
General ICU
Paracetamol and organ failures
Establish feeds
→ H20
→ No H20
Motility agent guidelines
Outcomes of Indigenous people in ICU
Lines with linkage to infection – retrospective review
Do we de-escalate antibiotics? Retrospective review
Prof Jeffrey Lipman +61 7 3636 8897 +61 7 3636 3542 [email protected]
Dr Jennifer Paratz +61 7 3636 1980 +61 7 3636 3542 [email protected]
Dr Sia Athanasas +61 7 3346 4932 +61 7 3365 5192 [email protected]
www2.som.uq.edu.au/som/Research/ResearchCentres/burnstraumacriticalcare
The University of Queensland, The School of Medicine, Royal Brisbane and Women’s Hospital, QLD, 4029.
Australia
Director: Prof Jeffrey Lipman
Chair: Dr Jennifer Paratz
Research Manager: Dr Sia Athanasas
pH/Nitrates in gastric aspirates what does it mean
Medical emergency team (MET) database – what are we doing with medical emergency responses,
outcome etc
When and what problems do we get into with tracheotomies – retrospective review
Lung haemorrhage Syndromes in ICU
Therapeutic Intervention Elective and bounce backs
Asthma management across ICUs
Thiopentone and hyperkalaenia
Vena Caval filters – incidence, outcome
What comes into the ICU that should not – high dependency admission guidelines.
How Do We Do Palliative Care Across Centres?
Intern experience in the ICU.
Bronchoscopy drug levels.
Bronchoscopy training for intensivists.
PICC line infectious thromboses
HFOV and humification
Inhaled Heparin study about to commence – to prevent VAP/ARDS
Lasix infusions (lasix levels) MVO2 kidney prevent renal contract and mannitol/aminophylline
Contrast and how much comes of on CVVHDF – benefit of early dialysis and does it prolong
duration of kidney injury?
MERT to cath lab – what are they like?
Who are the very long stays in ICU – longer than 6 months in ICU
– How many
– What’s wrong with them
– What happens to them.
Contact:
Assoc. Prof Rob Boots
3636 1849
[email protected]
Prof Jeffrey Lipman +61 7 3636 8897 +61 7 3636 3542 [email protected]
Dr Jennifer Paratz +61 7 3636 1980 +61 7 3636 3542 [email protected]
Dr Sia Athanasas +61 7 3346 4932 +61 7 3365 5192 [email protected]
www2.som.uq.edu.au/som/Research/ResearchCentres/burnstraumacriticalcare
The University of Queensland, The School of Medicine, Royal Brisbane and Women’s Hospital, QLD, 4029.
Australia
Director: Prof Jeffrey Lipman
Chair: Dr Jennifer Paratz
Research Manager: Dr Sia Athanasas
Anaesthesia and Sedation in ICU
Pharmacokinetics of dexmedetomidine in defined critical illness states. Suitable for PhD
Patient-controlled sedation using dexmedetomidine. Suitable for PhD
Dexmedetomidine vs. propofol effects on intracranial pressure & cerebrospinal fluid biomarkers in
TBI. Suitable for PhD
Analysis of data collected by registered nurse investigators in before/ after study of introduction of
a delirium monitoring scale. Suitable for PhD
Contact:
Prof Michael Reade
3365 5114
[email protected]
Critical Care Endocrinology
Plasma and Interstitial Fluid (ISF) levels of hydrocortisone in healthy volunteers randomised to CI
or IB. Suitable for PhD
Plasma and ISF levels of hydrocortisone in critically ill patients receiving vasopressors randomised
to CI or IB. Suitable for PhD
Plasma and ISF levels of hydrocortisone in critically ill patients with inflammatory lung disease
randomised to CI or IB. Suitable for PhD
Contact:
Dr Jeremy Cohen
[email protected]
Prof Jeffrey Lipman +61 7 3636 8897 +61 7 3636 3542 [email protected]
Dr Jennifer Paratz +61 7 3636 1980 +61 7 3636 3542 [email protected]
Dr Sia Athanasas +61 7 3346 4932 +61 7 3365 5192 [email protected]
www2.som.uq.edu.au/som/Research/ResearchCentres/burnstraumacriticalcare
Download

research topics - School of MedicineSchool of Medicine